ApprovalTrail

Approval · Notice of Compliance 11344 · 2010

ROSASOL: Notice of Compliance 11344

Issued April 30, 2010

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
11344
Date
April 30, 2010
Company
Glaxosmithkline IncMississauga, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Anti-rosacea

Products in this notice

BrandDINStatus today
ROSASOL02242919Cancelled Post Market

Medicinal ingredients